STAT3 and colitis: Our data indicate that this gp130/STAT3-mediatedimmunoprotection in DSS-induced colitis is independent of the previously reportedbeneficial effects of STAT3 activation on intestinal epithelial cells in animalmodels of colitis-associated tumorigenesis.